TileDB, Inc., Kepler AI, and Tahoe Therapeutics today announced a groundbreaking partnership to create the first public-facing platform that enables researchers to run sophisticated AI agent-based queries on massive single-cell datasets at unprecedented scale. This collaboration represents a major advancement in computational biology, combining TileDB's multimodal database technology with Kepler AI's agent systems and Tahoe Therapeutics' comprehensive single cell datasets.
Innovation Ventures congratulates Hani Goodarzi, Kevan Shokat, and Johnny Yu, the UCSF co-founders.